药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metocurine
Amobarbital
Amobarbital may increase the hypotensive activities of Empagliflozin.
Metocurine
Thiosalicylic acid
Thiosalicylic acid may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Choline salicylate
Choline salicylate may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Carbaspirin calcium
Carbaspirin calcium may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Guacetisal
Guacetisal may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Nitroaspirin
Nitroaspirin may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Trolamine salicylate
Trolamine salicylate may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Methyl salicylate
Methyl salicylate may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Phenyl aminosalicylate
Phenyl aminosalicylate may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Dersalazine
Dersalazine may increase the hypoglycemic activities of Empagliflozin.
Metocurine
Desvenlafaxine
The risk or severity of hypoglycemia can be increased when Desvenlafaxine is combined with Empagliflozin.
Metocurine
Liraglutide
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Empagliflozin.
Metocurine
Milnacipran
The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Empagliflozin.
Metocurine
Clinafloxacin
The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Empagliflozin.
Metocurine
Cibenzoline
The risk or severity of hypoglycemia can be increased when Cibenzoline is combined with Empagliflozin.
Metocurine
Alaproclate
The risk or severity of hypoglycemia can be increased when Alaproclate is combined with Empagliflozin.
Metocurine
Ritanserin
The risk or severity of hypoglycemia can be increased when Ritanserin is combined with Empagliflozin.
Metocurine
Ubidecarenone
The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Empagliflozin.
Metocurine
Indalpine
The risk or severity of hypoglycemia can be increased when Indalpine is combined with Empagliflozin.